NGFR and melanoma: As solTNF-mediated upregulation of CD271 (low affinity nerve growth factor receptor; p75NTR) has been reported to mediate resistance to MAPKi by BRAFV600E+ melanomas [10, 11], we also measured the expression of this receptor by flow cytometry.